$4.45
-0.05-1.11%
At close: -
$4.07
-0.38-8.48%
After Hours: 4:07 PM EDT
Comments
Loading...
Biodexa Pharmaceuticals (BDRX) Forecast
NewsEarningsBiodexa Pharmaceuticals (BDRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBiodexa Pharmaceuticals (NASDAQ:BDRX) Stock Quotes, Forecast and News Summary
Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biodexa Pharmaceuticals (BDRX) stock?
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Who are Biodexa Pharmaceuticals (BDRX) competitors?
Other companies in Biodexa Pharmaceuticals’s space includes: Fortress Biotech (NASDAQ:FBIO), Galectin Therapeutics (NASDAQ:GALT), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
What is the forecast, or price target, for Biodexa Pharmaceuticals (BDRX) stock?
Biodexa Pharmaceuticals has a consensus price target of $8.00.
What is the current price for Biodexa Pharmaceuticals (BDRX)?
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $4.0728 last updated January 6, 2025 at 4:07 PM EST.
Does Biodexa Pharmaceuticals (BDRX) pay a dividend?
There are no upcoming dividends for Biodexa Pharmaceuticals.
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals’s H1 earnings are confirmed for Friday, January 17, 2025.
Is Biodexa Pharmaceuticals (BDRX) going to split?
There is no upcoming split for Biodexa Pharmaceuticals.
What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.